| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | President & CEO
3 companies
Douglas S Ingram is Chief Executive Officer at SRPT and has filed Form 4s across 3 companies. Douglas S Ingram's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $20.4M at current prices.
The biggest single holding is SRPT (~$17.2M) as Chief Executive Officer. Net of sales, the SRPT filings show accumulation of 184,394 shares.
Douglas S Ingram has 22 Form 4 filings on record from June 2017 to June 2026, across 3 companies: Director at Relay Therapeutics (RLAY), 2020–2026; Director at Arrowhead Pharmaceuticals (ARWR), 2025; Chief Executive Officer at Sarepta Therapeutics (SRPT), 2017–2025.
The 32 reported transactions were 13 open-market purchases, 8 stock awards, 7 option or other derivative awards and 4 tax withholdings.
Counted by filing, the open-market trades come to 8 purchases worth about $14.5M and no sales.
The largest open-market purchase was 16,695 shares of SRPT at an average $120.39 on October 30, 2018, about $2.0M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2023 | SRPT Sarepta Therapeutics, Inc. | President & CEO | Buy | 25,225 | $79.36 | $2,001,799.89 | +6.9% | +57.5% | +58.0% | |
| Nov 17, 2021 | SRPT Sarepta Therapeutics, Inc. | President & CEO | Buy | 25,026 | $79.94 | $2,000,578.44 | +7.4% | +2.0% | +37.9% | |
| Jul 20, 2020 | RLAY Relay Therapeutics, Inc. | Director | Buy | 25,000 | $20.00 | $500,000.00 | New | - | - | |
| Aug 12, 2019 | SRPT Sarepta Therapeutics, Inc. | President & CEO | Buy | 16,252 | $123.07 | $2,000,160.32 | +3.9% | - | - | |
| Oct 30, 2018 | SRPT Sarepta Therapeutics, Inc. | President & CEO | Buy | 16,695 | $120.39 | $2,009,871.82 | +4.2% | - | - | |
| Aug 15, 2018 | SRPT Sarepta Therapeutics, Inc. | President & CEO | Buy | 16,000 | $125.26 | $2,004,211.20 | +4.2% | - | - | |
| Nov 8, 2017 | SRPT Sarepta Therapeutics, Inc. | President & CEO | Buy | 38,138 | $52.44 | $1,999,956.72 | +10.0% | - | - | |
| Jul 27, 2017 | SRPT Sarepta Therapeutics, Inc. | President & CEO | Buy | 47,058 | $42.50 | $1,999,965.00 | +14.0% | - | - |